CUAMC
China Universal Asset Management Company’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5K | Buy |
4,293
+14
| +0.3% | +$106 | ﹤0.01% | 440 |
|
|
2025
Q1 | $23.6K | Sell |
4,279
-215
| -5% | -$1.19K | ﹤0.01% | 453 |
|
|
2024
Q4 | $25.8K | Buy |
+4,494
| New | +$25.8K | ﹤0.01% | 479 |
|
|
2023
Q4 | – | Sell |
-548
| Closed | -$6.12K | – | 444 |
|
|
2023
Q3 | $6.12K | Buy |
548
+272
| +99% | +$3.04K | ﹤0.01% | 380 |
|
|
2023
Q2 | $5.91K | Sell |
276
-7
| -2% | -$150 | ﹤0.01% | 356 |
|
|
2023
Q1 | $11.4K | Buy |
283
+72
| +34% | +$2.91K | ﹤0.01% | 277 |
|
|
2022
Q4 | $9.82K | Buy |
211
+17
| +9% | +$791 | ﹤0.01% | 229 |
|
|
2022
Q3 | $10K | Buy |
+194
| New | +$10K | ﹤0.01% | 205 |
|